The use of carbapenems to eradicate multi-drug resistant (MDR) Acinetobacter baumannii may become compromised by the spread of carbapenem-hydrolyzing class D -lactamase (CHDL) genes . Here, we describe the phenotypical and genotypical characterization of MDR A. baumannii isolates, recovered between June and November 2003 in a tertiary-care hospital in Antalya, Turkey.
INTRODUCTION
Imipenem and meropenem are among the drugs of choice for treating nosocomial infections due to multidrug-resistant A. baumannii [1, 2] . However, their efficacy is being increasingly compromised and carbapenem-resistant isolates are becoming widespread in several regions of the world [3] [4] [5] . A large variety of molecular mechanisms for resistance to carbapenems have been reported in A. baumannii, i.e. acquisition of carbapenem-hydrolyzing -lactamases of molecular Ambler class B (metallo-enzymes) and mostly of class D enzymes (oxacillinases) but also rare mutations in genes coding for penicillin-binding proteins and decreased outer membrane permeability [5] [6] [7] [8] . Whereas class B enzymes found are of IMP and VIM types in A. baumannii [6] , the acquired carbapenem-hydrolyzing class D -lactamases (CHDL) are members of three subgroups of enzymes: the OXA-23-, OXA-24/40-and OXA-58-enzymes [3, 6] . OXA-58 shares less than 50% amino acid identity with the two other CHDL groups, which share 60 % amino acid sequence identity [6, 9] . Recently, a fourth subgroup of OXAlactamases sharing less than 63% amino acid identity with subgroups 1 and 2 has been identified [10, 11] . These enzymes (OXA-51 or 69-like) correspond to naturallyoccurring oxacillinases of A. baumannii and it is likely that their overexpression associated with a degree of outer membrane permeability defect may explain partially carbapenemresistance in A. baumannii [11] [12] [13] .
Outbreaks of OXA-23 or OXA-40-producing A. baumannii have been increasingly reported worldwide [3] . -Lactamase OXA-58 was first identified in France from a carbapenem-resistant A. baumannii isolate recovered in 2003 that was at the origin of an outbreak [9, 14] . This bla OXA-58 gene was plasmid-located. Since then, the bla OXA-58 gene has been identified worldwide [15, 16] and several outbreaks have been documented [17] [18] [19] [20] [21] . Genetic studies showed that the gene was bracketed by insertion sequences likely at the origin of its acquisition and its expression [22] .
The aim of this study was to analyze the molecular mechanisms of carbapenem resistance in A. baumannii isolates identified at the university hospital of Antalya, Turkey.
MATERIALS AND METHODOLOGY

Hospital Setting, Outbreak and Surveillance
Akdeniz University Hospital is a 746-bed tertiary-care teaching hospital with four ICUs totalizing 90 beds. The outbreak occurred on the fourth ICU with 12 beds and 4 single rooms. After the first isolation of MDR A. baumannii from the tracheal aspirate of a patient in the ICU in May 2003, a prospective surveillance study was initiated in order to determine the epidemiology of MDR A. baumannii, and infection control measures were strengthened according to the recommendations of Centres for Disease Control and Prevention by the Infection Control Committee of the hospital [23] . After the first isolation of MDR A. baumannii, a screening programme was initiated. Samples were taken once a week from all patients hospitalized in the ICU and for all newly admitted patients as well as the environmental cultures. Environmental sampling included: (i) swabs taken from the patient's direct environment including medical devices; (ii) swabs from handwashing sinks; and (iii) fintertips of healthcare workers. Samples were taken using cottontipped swabs moistened with sterile saline. Swabs, rinsing fluid and fingertips of healthcare workers were cultured on antibiotic-supplemented (imipenem 2 g/ml) and standard MacConkey agar plates and incubated aerobically at 37°C for up to 48 h. In addition to contact precautions, stringent compliance with standard precautions, especially the use of alcohol-based hand-rub solutions, was strongly recommended for all patients in the ward regardless of their bacteriological status. Active surveillance was continued until three months after the last colonized patient was discharged. Thus in March 2004, the epidemic was officially considered over and the surveillance programme returned to a normal operation level (Fig. 1) .
Bacterial Strains Antimicrobial Agents and MIC Determinations
A. baumannii isolates was identified by means of a commercial identification gallery (API 32GN system, BioMérieux, Marcy-l'Etoile, France). Identification of A. baumannii isolates was confirmed by detection and sequencing of the intrinsic bla oxa-51/69 -like gene [24] . A. baumannii MAD [9] , A. baumannii Gr-1 [19] , A. baumannii Ank-1 and A. baumannii Ist-1 [15] was used as a reference strains for PCR mappings and PFGE. A. baumannii CIP7010 and Escherichia coli DH10B were used for electroporation, and azide-resistant E. coli J53 or rifampin-resistant A. baumannii CIP7010 for conjugation. E. coli NCTC 50192 harbouring 154-, 66-, 38-, and 7-kb plasmids was used as a plasmid-containing reference strain [17] .
Antimicrobial susceptibility testing was determined by disk diffusion method using interpretative criteria of the Clinical and Laboratory Standard Institute (CLSI) [25] . MICs of the different antibiotics were determined by E-test (AB Biodisk, Solna, Sweden) according to manufacturer's instructions and interpreted according to CLSI, and Eucast for colistin and tigecyclin.
PFGE
Pulsed-field gel electrophoresis (PFGE) was performed with ApaI-restricted whole-cell DNAs embedded in 1% agarose plugs and separated in a 1% pulsed field-certified agarose gel using a contour-clamped homogeneous electric field DRII system (Bio-Rad, Marnes-La-Coquette, France), as previously described [26] . PFGE results were analysed by eye according to the criteria of Tenover et al. [27] .
Plasmid Content, Electroporation and Mating Out Experiments
Direct transfer of resistance into azide-resistant E. coli J53 or to rifampin-resistant A. baumannii CIP7010 (MIC >256 g/mL) was attempted as previously reported [17] . Extraction of plasmid DNA from A. baumannii isolates was attempted using the Kieser extraction method [28] . Plasmid extracts were analyzed by electrophoresis on a % 0, 7 agarose gel [9] . Extracted plasmids were electroporated into A. baumannii CIP7010 and E. coli DH10B strains using a Gene Pulser II electroporator (Bio-Rad, Ivry-sur-Seine, France). Electroporants were selected on ticarcillin (50 g/ml)-containing TSA plates.
Isoelectric Focusing (IEF) Analyses and Biochemical Properties
Crude -lactamase extracts were obtained from 10-ml cultures of A. baumannii and analytical isoelectric focusing Fig. (1) . Epidemic curve.
(IEF) was performed with an ampholine polyacrylamide gel, as described previously [17] . The specific carbapenem hydrolysis was measured as described [17] .
PCR Analyses and Sequencing
Genomic DNA extraction and PCR experiments were performed as previously described [17, 26] . The PCR amplification and the primers used to search for knownlactamase genes of Ambler class B and D carbapenemases were sought by PCR with primers specific for the bla IMP , bla VIM , bla KPC , bla OXA-23 -like, bla OXA-40 -like, and bla OXA-58 genes and for Ambler class A bla TEM , bla SHV , bla PER-1/2 , bla VEB-1 , bla GES-1 and bla CTX-M in A. baumannii isolates have been described previously [17, 26] . Detection of the bla AmpCtype and bla OXA-69 genes of A. baumannii was performed with primers listed in Table 1 which hybridized to internal parts but also to outer parts of these -lactamase genes [17, 26] . The presence of ISAba1 inserted upstream of a bla AmpC and bla OXA-69 -like -lactamase gene were also sought by PCR [12, 29] .
For PCR-mapping experiments of the genetic environment of bla OXA-58 , 500 ng of total DNA of A. baumannii isolates were used in standard PCR reaction mixtures [9, 17] . The PCR primers are listed in Table 1 and Fig. (2A) . The following amplification program was used: 10 min, 94ºC; 35 cycles of 1 min, 94ºC, 1 min, 55ºC, 3-5 min, 72ºC; followed by a final extension of 10 min at 72ºC. PCR products were purified using QIAquick PCR Purification Kit (Qiagen, Les Ulis France) and subsequently sequenced on both strands on an Applied Biosystem sequencer (ABI 3100, Les Ulis, France). Nucleotide sequence analysis was performed at the National Centre of Biotechnology Information website (http://www.ncbi.nlm.nih.gov).
The nucleotide sequences reported in this paper have been assigned to the GenBank nucleotide database. Table 2 ). The ages of the patients ranged from 3 to 75 years (mean age, 36, 5 years). Seventeen patients were infected (74%) and 6 (26%) were colonized according to guidelines from Centre for Diseases Control and Prevention [23] . Most of the A. baumannii pre-oxa-69B 20 CCAGTGGATGGATAGATTATC [17] were isolated from the respiratory tract (42 respiratory samples from 20 patients) in ICU patients. Environmental samples that were positive for A. baumannii were taken from the ICU unit, consisted of 5 hand cultures from staff, 2 from respiratory devices, 3 from respiratory monitors and 1 from dressing medical devices (Table 3) . A. baumannii isolates were resistant to all -lactams, including imipenem (MIC: 32 g/mL) and meropenem (MIC: 4 to >32 g/mL), to ciprofloxacin (MIC: >32 g/mL), and to amikacin (MIC: > 256 g/mL). Variable susceptibility was found for rifampin (MIC: 4 to >256 g/mL). The isolates were resistant to tigecyclin (MIC: 12 g/mL) and borderline susceptible to colistin (MIC: 3 g/mL). Strain 1 isolated from patient 1 (index patient) on the day of his admission showed higher MICs for sulbactam (32 g/mL), meropenem (>32 g/mL) and imipenem (>32 g/mL). Several strains had variable sulbactam: 8-32 g/mL, imipenem: 4-32 g/mL meropenem: 8-32 g/mL and tazobactam: 32-256 g/mL susceptibility suggesting that resistant strains even though clonally-related might exhibit different pattern of resistance.
RESULTS
Epidemiology and Surveillance
While not yet fully understood, this phenomenon was already reported in A. baumannii [17] . It is tempting to suggest that rearrangements in plasmids and/or modification in outer membrane proteins (OMPs) could account for the different MIC values. By contrast two strains (7a and 7b) were isolated the same day from patient 7, differing only by the imipenem-resistance; strain 7b being susceptible both to imipenem (MIC: 4 g/mL) and to meropenem (MIC: 4 g/mL) ( Table 2) .
PCR Analysis, IEF and Carbapenem Hydrolysis
One A. baumannii isolate per patient, except for patient 7 where two strains were retained, and 2 environmental isolates were further investigated. These A. baumannii isolates were positive for bla OXA-58 -like and the chromosomallylocated bla OXA-51 -like and bla AMPC genes. The carbapenemsusceptible strain 7b was positive only for bla OXA-51 -like and for bla AMPC genes. Significant carbapenem-hydrolysis was found for all isolates except for strain 7b. Isoelectricfocusing confirmed the expression of OXA-58 (pI 7.0) and AmpC (pI > 8.5) (data not shown). Sequencing of the amplified fragments confirmed the presence of these genes and showed that the bla OXA-58 gene was identical to that of the prototype OXA-58 -lactamase described in Toulouse [9] and of other southern European regions [15, 19, 20] , thus underscoring the wide geographical spread of this gene. Sequencing of bla OXA-51 -like gene revealed the presence of the bla OXA-76 gene previously described in A. baumannii isolates from different regions (Spain, Turkey, Hong Kong and Singapore) [10] . and araC2) , the threonine efflux protein gene (lysE), the esterase gene (Est), the putative regulatory gene (reg), the gene encoding an ORF of unknown function (orf), the putative transposase gene (tnpA), and the putative resolvase gene (res) are indicated. Vertical arrows are for the Re27-like sequences. The genetic structure which is highly similar between [1] and (2) is indicated with the dotted lines. The primers are indicated under arrows and the number correspond to the table. [27] . All isolates were imipenem-resistant and positive for blaOXA-58 by PCR (except strain 7b and E1). ICU : intensive care unit.
Sequencing of bla AmpC gene and deduction of its amino acid sequence revealed two changes (E322V; N341S) with the mobilized version of A. baumannii AMPC, aba-1 found in Oligella urethalis AMPC [30] . The sequence was assigned theADC number ADC-43. The closest bla AmpC was bla ADC-7 gene, with 98% similarity (16 nucleotide leading to 5 amino acid changes). ISAba1 was found in A. baumannii inserted upstream of bla AMPC genes [31] .
Genetic Environment
PCR mapping showed that upstream of bla OXA-58 , an ISAba3-like element was found, that was not truncated by IS26, ISAba1 or ISAba2 elements as already described. In fact, PCR experiments failed to amplify the entire IS element, suggesting that the element might be truncated at its 5'-extremity, as already described [22] (Fig. 2) . Downstream of the bla OXA-58 gene, an entire copy of ISAba3 was identified, followed by the araC1 and lysE genes, as observed in natural plasmid pMAD [22] . Downstream of the lysE gene, a sequence similar to what has been defined as the Re27-2 structure in A. baumannii MAD was identified. This structure has been proposed to be at the origin of the acquisition of the bla OXA-58 gene in that latter strain [22] . Then, an araC2-like gene was identified as found in A. baumannii MAD (Fig. 2) . Downstream of araC2, a gene encoding a putative regulator was found, followed by an orf corresponding to a putative 160 amino-acid long protein, followed by a gene encoding a putative transposase. 
Genetic Location
In line with previous findings [9, 22] , the bla OXA-58 gene was plasmid mediated. In all carbapenem-resistant isolates, a 50-kb plasmid was present but it was not self-transferable to rifampin-resistant A. baumannii strain. Electroporation with isolated plasmid into A. baumannii CIP7010 revealed that the bla OXA-58 gene was identified in those electroporants, but not in E. coli. Heritier et al. [32] demonstrated that OXA-58 has a weak carbapenemase activity and plays a role in carbapenem resistance in A. baumannii, particularly when highly expressed. MICs of transconjugants were identical to those already obtained with natural plasmid pMAD expressing OXA-58 (data not shown).
PFGE Analysis
The carbapenem-resistant A. baumannii isolates gave similar PFGE patterns (Fig. 3) , differing by only three bands for some isolates. The imipenem-susceptible 7b isolate from patient 7 showed the same PFGE pattern as the carbapenemresistant 7a strains (Fig. 3) , but was lacking bla . This observation confirms, as recently suggested by Bogearts et al. [17] , that OXA-58-producing A. baumannii isolates may occasionally loose the bla OXA-58 gene and its surrounding genetic structure in the absence of carbapenem selection pressure. No plasmid could be evidenced in that isolate, suggesting that the entire plasmid containing bla OXA-58 gene was lost. The bla OXA-76 gene was however detected by PCR in that strain, further suggesting that these -lactamase genes may be present in carbapenem-susceptible strains as shown by Héritier et al. [10] . Very recently, A. baumannii OXA-58 isolates have been described in Greece and in Turkey [15, 22] . When the isolates of Antalya were compared to these strains, a genetic relationship could be established with the Turkish isolates but not with the Greek strain, suggesting that a single clone can be found in several regions of Turkey (Fig. 3) [22] .
DISCUSSION
Infections with A. baumannii are of great concern for hospitalized patients, showing the highest individual rate of incidence, particularly, in the intensive care units [3] . MDR A. baumannii clones are spreading throughout many different geographic areas [20] and treatment options for MDR A. baumannii infections are limited in most cases to carbapenems. The emergence of imipenem resistance means that sulbactam, colistin and perhaps tigecyclin may be the only therapeutic options for treating infections caused by these strains. The high level of resistance to imipenem in A. baumannii clinical isolates and the clinical risk factors favouring the acquisition of imipenem-resistant A. baumannii have been reported previously [3, 4] . Although carbapenem resistance may be caused, in part by impaired permeability, resulting from decreased expression of porins, or by modifications in penicillin-binding proteins [3, 6] , most recent reports have indicated that carbapenem-hydrolysing -lactamases especially the OXA-types play a major role [32] .
After the initial report in Toulouse, France [9] , OXA-58-producing A. baumannii isolates have been reported in several countries around the world suggesting a wide distribution [15, 16] . In Europe, they have been reported in Greece, Italy, Turkey, Spain, and Belgium [15, 16, 22] . Hospitals outbreaks have been so far documented in France, Belgium, Italy, Greece and in Tunisia [17] [18] [19] [20] [21] . In Belgium, the isolation was subsequent of a patient transfer from Greece [17] . This is the first description of an outbreak of OXA-58 producing A. baumannii isolates in Turkey. Importantly, the fact that a large outbreak arose in the hospital despite early implementation of appropriate barrier precautions underlines the epidemic potential of such resistant strains.
This bacterial species naturally produces a chromosomally-encoded cephalosporinase that may be overexpressed due to insertion of ISAba1, which brings promoter sequences necessary for high-level expression of thislactamase [29] . As observed for the other carbapenemhydrolyzing oxacillinase genes, bla OXA-58 was not present in the form of a gene cassette in a class 1 integron, a situation that contrasts to that found for most of the oxacillinase genes. The genetic structures surrounding the bla OXA-58 gene were similar to those identified in association with the bla OXA-58 gene in a series of isolates identified from France, Italy or Greece [22] , indicating that a common structure has been at the origin of the dissemination of these genes. In addition, the IS element located upstream of bla OXA-58 gene has been suggested to be responsible of high level expression by providing strong promoter sequences [22] . Furthermore, our study evidenced that bla OXA-58 -positive plasmids might be lost suggesting a genetic instability of these A baumannii specific plasmids.
Contaminated hands and gloves of the ward staff seem to have an important role in patient-to patient transmission of A. baumannii [1, 2, 3, 17] . In our study, 25% of the samples collected from hands of ICU personnel were positive for imipenem-resistant A. baumannii. In addition, the detection of a common clone among environmental and clinical imipenem-resistant A. baumannii indicates that environmental contamination contributes to the difficulty in restricting spread of this organism in the hospital. This outbreak was restricted to only one ICU because the four ICUs are independent and geographically separated from each other, with dedicated nursing and medical staffs. Furthermore, patient transfer between the ICUs were rare and during the epidemic period were totally restricted. Surveillance cultures and strict antiseptic techniques possibly reduced the further spread of these bacteria.
This report constitutes the first report of a nosocomial dissemination of an OXA-58 producing A. baumannii strain in Turkey, after identification single OXA-58-producing A. baumannii isolates from this country [15, 33] . The current worldwide emergence of multiresistant A. baumannii isolates is mostly associated to acquisition of carbapenem-resistance determinants. Therefore, carbapenemases seem to be the main cause of carbapenem-resistance in A. baumannii and thus have to be considered as the main target for development of inhibitors. Prospective surveillance programs by characterization of antibiotic resistance, genotyping and plasmid analysis will be useful to follow the recurrence of the described A. baumannii clone as well as to rapidly detect genotype and resistance pattern changes in new emerging clones in our country.
